Research

Energy balance

Approximately two-thirds of patients showed stable weight or continued weight loss during the 6 months following their last semaglutide or tirzepatide prescription.

Practitioners can expect that a significant portion of patients may maintain or lose weight after discontinuing GLP-1RA.

StrongSupportsmedium confidence
Approximately two-thirds of patients showed stable weight or continued weight loss during this period.
Karthik Murugadoss et al. · Biology Methods and Protocols · 2026

Why this rating

Based on the large sample size of 4182 patients.

Source

Weight trajectories after last tirzepatide or semaglutide prescription across a federated health network

Karthik Murugadoss et al. · Biology Methods and Protocols · 2026

DOI 10.1093/biomethods/bpag020

cohort · n=4182
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →